{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:18:52Z","timestamp":1783577932826,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11046-023-00739-9","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T13:01:49Z","timestamp":1684587709000},"page":"655-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a Literature Review of Test Performances in Different Patient Populations"],"prefix":"10.1007","volume":"188","author":[{"given":"Robina","family":"Aerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lize","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-1350","authenticated-orcid":false,"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMra2027424","volume":"385","author":"GR Thompson","year":"2021","unstructured":"Thompson GR, Young JAH. Aspergillus infections. New Engl J Med. 2021;385:1496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra2027424.","journal-title":"New Engl J Med"},{"key":"739_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/myc.13205","volume":"64","author":"L Souza","year":"2021","unstructured":"Souza L, Nou\u00e9r SA, Morales H, Sim\u00f5es B, Solza C, Queiroz-Telles F, et al. Epidemiology of invasive fungal disease in haematologic patients. Mycoses. 2021;64:252\u20136. https:\/\/doi.org\/10.1111\/myc.13205.","journal-title":"Mycoses"},{"key":"739_CR3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524\u201335. https:\/\/doi.org\/10.1007\/s00134-020-06091-6.","journal-title":"Intensive Care Med"},{"key":"739_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71:1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Dis"},{"key":"739_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12889-019-6932-9","volume":"19","author":"MD Zilberberg","year":"2019","unstructured":"Zilberberg MD, Harrington R, Spalding JR, Shorr AF. Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004\u20132013. BMC Public Health. 2019;19:591. https:\/\/doi.org\/10.1186\/s12889-019-6932-9.","journal-title":"BMC Public Health"},{"key":"739_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/cid\/ciw592","volume":"63","author":"T Lehrnbecher","year":"2016","unstructured":"Lehrnbecher T, Robinson PD, Fisher BT, Castagnola E, Groll AH, Steinbach WJ, et al. Galactomannan, \u03b2-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Infect Dis. 2016;63:1340\u20138. https:\/\/doi.org\/10.1093\/cid\/ciw592.","journal-title":"Clin Infect Dis"},{"key":"739_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1128\/JCM.33.2.497-500.1995","volume":"33","author":"D Stynen","year":"1995","unstructured":"Stynen D, Goris A, Sarfati J, Latg\u00e9 JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol. 1995;33:497\u2013500. https:\/\/doi.org\/10.1128\/JCM.33.2.497-500.1995.","journal-title":"J Clin Microbiol"},{"key":"739_CR8","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"key":"739_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","volume":"4","author":"MA Mennink-Kersten","year":"2004","unstructured":"Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis. 2004;4:349\u201357. https:\/\/doi.org\/10.1016\/S1473-3099(04)01045-X.","journal-title":"Lancet Infect Dis"},{"key":"739_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fmicb.2018.00661","volume":"9","author":"T Mercier","year":"2018","unstructured":"Mercier T, Guldentops E, Lagrou K, Maertens J. Galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age. Front Microbiol. 2018;9:661. https:\/\/doi.org\/10.3389\/fmicb.2018.00661.","journal-title":"Front Microbiol"},{"key":"739_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1128\/CVI.00068-08","volume":"15","author":"CR Thornton","year":"2008","unstructured":"Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008;15:1095\u2013105. https:\/\/doi.org\/10.1128\/CVI.00068-08.","journal-title":"Clin Vaccine Immunol"},{"key":"739_CR12","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1128\/JCM.40.11.4382-4387.2002","volume":"40","author":"PCY Woo","year":"2002","unstructured":"Woo PCY, Chan C-M, Leung ASP, Lau SKP, Che X-Y, Wong SSY, et al. Detection of cell wall galactomannoprotein Afmp1p in culture supernatants of Aspergillus fumigatus and in sera of aspergillosis patients. J Clin Microbiol. 2002;40:4382\u20137. https:\/\/doi.org\/10.1128\/JCM.40.11.4382-4387.2002.","journal-title":"J Clin Microbiol"},{"key":"739_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0140-6736(95)91152-9","volume":"345","author":"T Obayashi","year":"1995","unstructured":"Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, et al. Plasma (1\u2013>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(95)91152-9.","journal-title":"Lancet"},{"key":"739_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jinf.2018.10.014","volume":"78","author":"JD Jenks","year":"2019","unstructured":"Jenks JD, Mehta SR, Taplitz R, Law N, Reed SL, Hoenigl M. Bronchoalveolar lavage Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J Infect. 2019;78:249\u201359. https:\/\/doi.org\/10.1016\/j.jinf.2018.10.014.","journal-title":"J Infect"},{"key":"739_CR15","doi-asserted-by":"publisher","first-page":"e00053","DOI":"10.1128\/JCM.00053-20","volume":"58","author":"PL White","year":"2020","unstructured":"White PL, Price JS, Posso R, Cutlan-Vaughan M, Vale L, Backx M. Evaluation of the performance of the IMMY sona Aspergillus galactomannan lateral flow assay when testing serum to aid in diagnosis of invasive aspergillosis. J Clin Microbiol. 2020;58:e00053-e120. https:\/\/doi.org\/10.1128\/JCM.00053-20.","journal-title":"J Clin Microbiol"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","volume":"4","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Hoenigl M, Gangneux J-P, Segal E, Alastruey-Izquierdo A, Arikan Akdagli S, et al. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey. Lancet Microbe. 2023;4:e47-56. https:\/\/doi.org\/10.1016\/S2666-5247(22)00261-0.","journal-title":"Lancet Microbe"},{"key":"739_CR17","unstructured":"Belgium Population. Worldometer n.d. 2023. https:\/\/www.worldometers.info\/world-population\/belgium-population\/. Accessed 5 Jan 2023."},{"key":"739_CR18","unstructured":"Report for Selected Countries and Subjects. IMF n.d. https:\/\/www.imf.org\/en\/Publications\/WEO\/weo-database\/2022\/October\/weo-report. Accessed 5 Jan 2023."},{"key":"739_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/myc.12389","volume":"58","author":"K Lagrou","year":"2015","unstructured":"Lagrou K, Maertens J, Van Even E, Denning DW. Burden of serious fungal infections in Belgium. Mycoses. 2015;58:1\u20135. https:\/\/doi.org\/10.1111\/myc.12389.","journal-title":"Mycoses"},{"key":"739_CR20","doi-asserted-by":"publisher","first-page":"e00136","DOI":"10.1128\/JCM.00136-19","volume":"57","author":"K Dichtl","year":"2019","unstructured":"Dichtl K, Seybold U, Ormanns S, Horns H, Wagener J. Evaluation of a novel Aspergillus antigen enzyme-linked immunosorbent assay. J Clin Microbiol. 2019;57:e00136-e219. https:\/\/doi.org\/10.1128\/JCM.00136-19.","journal-title":"J Clin Microbiol"},{"key":"739_CR21","doi-asserted-by":"publisher","first-page":"e0262621","DOI":"10.1128\/spectrum.02626-21","volume":"10","author":"AL Calero","year":"2022","unstructured":"Calero AL, Alonso R, Gadea I, Vega MDM, Garc\u00eda MM, Mu\u00f1oz P, et al. Comparison of the performance of two galactomannan detection tests: Platelia Aspergillus Ag and Aspergillus galactomannan Ag virclia monotest. Microbiol Spectr. 2022;10:e0262621. https:\/\/doi.org\/10.1128\/spectrum.02626-21.","journal-title":"Microbiol Spectr"},{"key":"739_CR22","doi-asserted-by":"publisher","first-page":"1563.e1","DOI":"10.1016\/j.cmi.2019.08.009","volume":"25","author":"C Lass-Fl\u00f6rl","year":"2019","unstructured":"Lass-Fl\u00f6rl C, Lo Cascio G, Nucci M, Camargo Dos Santos M, Colombo AL, Vossen M, et al. Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMYTM): real-life data from a multicentre study. Clin Microbiol Infect. 2019;25:1563.e1-1563.e3. https:\/\/doi.org\/10.1016\/j.cmi.2019.08.009.","journal-title":"Clin Microbiol Infect"},{"key":"739_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/myc.12694","volume":"61","author":"CG Castillo","year":"2018","unstructured":"Castillo CG, Kauffman CA, Zhai J, Jiang H, Agozino SM, Miceli MH. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients. Mycoses. 2018;61:4\u201310. https:\/\/doi.org\/10.1111\/myc.12694.","journal-title":"Mycoses"},{"key":"739_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4067\/s0716-10182018000500574","volume":"35","author":"I Delama","year":"2018","unstructured":"Delama I, Legarraga P, Gonz\u00e1lez T, Garc\u00eda P, Rabagliati R. Evaluation of the lateral flow Aspergillus assay for the diagnosis of invasive aspergillosis, experience in a university hospital. Rev Chilena Infectol. 2018;35:574\u20139. https:\/\/doi.org\/10.4067\/s0716-10182018000500574.","journal-title":"Rev Chilena Infectol"},{"key":"739_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","volume":"19","author":"S Eigl","year":"2015","unstructured":"Eigl S, Prattes J, Lackner M, Willinger B, Spiess B, Reinwald M, et al. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients. Crit Care. 2015;19:178. https:\/\/doi.org\/10.1186\/s13054-015-0905-x.","journal-title":"Crit Care"},{"key":"739_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","volume":"46","author":"S Eigl","year":"2015","unstructured":"Eigl S, Prattes J, Reinwald M, Thornton CR, Reischies F, Spiess B, et al. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents. 2015;46:401\u20135. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.05.017.","journal-title":"Int J Antimicrob Agents"},{"key":"739_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","volume":"77","author":"S Heldt","year":"2018","unstructured":"Heldt S, Prattes J, Eigl S, Spiess B, Flick H, Rabensteiner J, et al. Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect. 2018;77:235\u201341. https:\/\/doi.org\/10.1016\/j.jinf.2018.05.001.","journal-title":"J Infect"},{"key":"739_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/myc.12704","volume":"61","author":"M Hoenigl","year":"2018","unstructured":"Hoenigl M, Eigl S, Heldt S, Duettmann W, Thornton C, Prattes J. Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis. Mycoses. 2018;61:40\u20133. https:\/\/doi.org\/10.1111\/myc.12704.","journal-title":"Mycoses"},{"key":"739_CR29","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/JCM.00467-14","volume":"52","author":"M Hoenigl","year":"2014","unstructured":"Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52:2039\u201345. https:\/\/doi.org\/10.1128\/JCM.00467-14.","journal-title":"J Clin Microbiol"},{"key":"739_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jinf.2012.10.003","volume":"65","author":"M Hoenigl","year":"2012","unstructured":"Hoenigl M, Koidl C, Duettmann W, Seeber K, Wagner J, Buzina W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012;65:588\u201391. https:\/\/doi.org\/10.1016\/j.jinf.2012.10.003.","journal-title":"J Infect"},{"key":"739_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/myc.12881","volume":"62","author":"JD Jenks","year":"2019","unstructured":"Jenks JD, Mehta SR, Taplitz R, Aslam S, Reed SL, Hoenigl M. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test in bronchoalveolar lavage. Mycoses. 2019;62:230\u20136. https:\/\/doi.org\/10.1111\/myc.12881.","journal-title":"Mycoses"},{"key":"739_CR32","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1128\/JCM.00110-15","volume":"53","author":"GL Johnson","year":"2015","unstructured":"Johnson GL, Sarker S-J, Nannini F, Ferrini A, Taylor E, Lass-Fl\u00f6rl C, et al. Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2015;53:2103\u20138. https:\/\/doi.org\/10.1128\/JCM.00110-15.","journal-title":"J Clin Microbiol"},{"key":"739_CR33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/myc.13012","volume":"62","author":"KA Linder","year":"2019","unstructured":"Linder KA, Kauffman CA, Zhou S, Miceli MH. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis. Mycoses. 2019;62:1189\u201393. https:\/\/doi.org\/10.1111\/myc.13012.","journal-title":"Mycoses"},{"key":"739_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/mmy\/myz079","volume":"58","author":"T Mercier","year":"2020","unstructured":"Mercier T, Dunbar A, de Kort E, Schauwvlieghe A, Reynders M, Guldentops E, et al. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study. Med Mycol. 2020;58:444\u201352. https:\/\/doi.org\/10.1093\/mmy\/myz079.","journal-title":"Med Mycol"},{"key":"739_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01913-18","author":"T Mercier","year":"2019","unstructured":"Mercier T, Schauwvlieghe A, de Kort E, Dunbar A, Reynders M, Guldentops E, et al. Diagnosing invasive pulmonary aspergillosis in hematology patients: a retrospective multicenter evaluation of a novel lateral flow device. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01913-18.","journal-title":"J Clin Microbiol"},{"key":"739_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/myc.12327","volume":"58","author":"MH Miceli","year":"2015","unstructured":"Miceli MH, Goggins MI, Chander P, Sekaran AK, Kizy AE, Samuel L, et al. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis. Mycoses. 2015;58:368\u201374. https:\/\/doi.org\/10.1111\/myc.12327.","journal-title":"Mycoses"},{"key":"739_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/myc.12343","volume":"58","author":"J Prattes","year":"2015","unstructured":"Prattes J, Lackner M, Eigl S, Reischies F, Raggam RB, Koidl C, et al. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses. 2015;58:461\u20139. https:\/\/doi.org\/10.1111\/myc.12343.","journal-title":"Mycoses"},{"key":"739_CR38","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","volume":"190","author":"J Prattes","year":"2014","unstructured":"Prattes J, Flick H, Pr\u00fcller F, Koidl C, Raggam RB, Palfner M, et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014;190:922\u20139. https:\/\/doi.org\/10.1164\/rccm.201407-1275OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"739_CR39","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3389\/fmicb.2018.02223","volume":"9","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF, Prattes J, Flick H, Reimann M, Heyckendorf J, Kalsdorf B, et al. Evaluation of galactomannan testing, the Aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis. Front Microbiol. 2018;9:2223. https:\/\/doi.org\/10.3389\/fmicb.2018.02223.","journal-title":"Front Microbiol"},{"key":"739_CR40","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/myc.13176","volume":"63","author":"U Scharmann","year":"2020","unstructured":"Scharmann U, Verhasselt HL, Kirchhoff L, Buer J, Rath P-M, Steinmann J, et al. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: a retrospective two-centre study. Mycoses. 2020;63:1362\u20137. https:\/\/doi.org\/10.1111\/myc.13176.","journal-title":"Mycoses"},{"key":"739_CR41","doi-asserted-by":"publisher","first-page":"e00095","DOI":"10.1128\/JCM.00095-19","volume":"57","author":"T Takazono","year":"2019","unstructured":"Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, et al. Evaluation of Aspergillus-specific lateral-flow device test using serum and bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis. J Clin Microbiol. 2019;57:e00095-e119. https:\/\/doi.org\/10.1128\/JCM.00095-19.","journal-title":"J Clin Microbiol"},{"key":"739_CR42","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/TP.0000000000000153","volume":"98","author":"B Willinger","year":"2014","unstructured":"Willinger B, Lackner M, Lass-Fl\u00f6rl C, Prattes J, Posch V, Selitsch B, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study. Transplantation. 2014;98:898\u2013902. https:\/\/doi.org\/10.1097\/TP.0000000000000153.","journal-title":"Transplantation"},{"key":"739_CR43","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/CM9.0000000000002050","volume":"135","author":"W Xiao","year":"2022","unstructured":"Xiao W, Du L, Cai L, Miao T, Mao B, Wen F, et al. Existing tests versus novel non-invasive assays for detection of invasive aspergillosis in patients with respiratory diseases. Chin Med J (Engl). 2022;135:1545\u201354. https:\/\/doi.org\/10.1097\/CM9.0000000000002050.","journal-title":"Chin Med J (Engl)"},{"key":"739_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00948-22","author":"R Aerts","year":"2022","unstructured":"Aerts R, Mercier T, Houben E, Schauwvlieghe A, Lagrou K, Maertens J. Performance of the JF5-based galactomannoprotein EIA compared to the lateral flow device and the galactomannan EIA in serum and bronchoalveolar lavage fluid. J Clin Microbiol. 2022. https:\/\/doi.org\/10.1128\/jcm.00948-22.","journal-title":"J Clin Microbiol"},{"key":"739_CR45","doi-asserted-by":"publisher","first-page":"e26025","DOI":"10.7759\/cureus.26025","volume":"14","author":"CP Chaturvedi","year":"2022","unstructured":"Chaturvedi CP, Hashim Z, Tripathy NK. A new and highly sensitive serum mannoprotein lateral flow assay for point-of-care diagnosis of invasive aspergillosis (Tripathy method). Cureus. 2022;14:e26025. https:\/\/doi.org\/10.7759\/cureus.26025.","journal-title":"Cureus"},{"key":"739_CR46","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200746","author":"R Felek","year":"2021","unstructured":"Felek R, Erman-Daloglu A, Ozhak B, Ogunc D, Ongut G, Gunseren F, et al. Evaluation of Aspergillus lateral-flow test in serum samples of pediatric patients. Clin Lab. 2021. https:\/\/doi.org\/10.7754\/Clin.Lab.2020.200746.","journal-title":"Clin Lab"},{"key":"739_CR47","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s15010-013-0472-5","volume":"41","author":"J Held","year":"2013","unstructured":"Held J, Schmidt T, Thornton CR, Kotter E, Bertz H. Comparison of a novel Aspergillus lateral-flow device and the Platelia\u00ae galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection. 2013;41:1163\u20139. https:\/\/doi.org\/10.1007\/s15010-013-0472-5.","journal-title":"Infection"},{"key":"739_CR48","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.jfma.2022.04.011","volume":"121","author":"H-H Hsiao","year":"2022","unstructured":"Hsiao H-H, Liu Y-C, Wang H-C, Du J-S, Tang S-H, Yeh T-J, et al. Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis. J Formos Med Assoc. 2022;121:2123\u20139. https:\/\/doi.org\/10.1016\/j.jfma.2022.04.011.","journal-title":"J Formos Med Assoc"},{"key":"739_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa295","author":"T Mercier","year":"2020","unstructured":"Mercier T, Guldentops E, Lagrou K, Maertens J. Prospective evaluation of the turbidimetric \u03b2-D-glucan assay and 2 lateral flow assays on serum in invasive aspergillosis. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa295.","journal-title":"Clin Infect Dis"},{"key":"739_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12288-016-0653-3","volume":"33","author":"G Metan","year":"2017","unstructured":"Metan G, Keklik M, Din\u00e7 G, Pala \u00c7, Y\u0131ld\u0131r\u0131m A, Saraymen B, et al. Performance of galactomannan antigen, beta-d-glucan, and Aspergillus-lateral-flow device for the diagnosis of invasive aspergillosis. Indian J Hematol Blood Transfus. 2017;33:87\u201392. https:\/\/doi.org\/10.1007\/s12288-016-0653-3.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"739_CR51","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/JCM.03189-12","volume":"51","author":"PL White","year":"2013","unstructured":"White PL, Parr C, Thornton C, Barnes RA. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol. 2013;51:1510\u20136. https:\/\/doi.org\/10.1128\/JCM.03189-12.","journal-title":"J Clin Microbiol"},{"key":"739_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/mmy\/myaa113","volume":"59","author":"P Arkell","year":"2021","unstructured":"Arkell P, Mahboobani S, Wilson R, Fatania N, Coleman M, Borman AM, et al. Bronchoalveolar lavage fluid IMMY sona Aspergillus lateral-flow assay for the diagnosis of invasive pulmonary aspergillosis: a prospective, real life evaluation. Med Mycol. 2021;59:404\u20138. https:\/\/doi.org\/10.1093\/mmy\/myaa113.","journal-title":"Med Mycol"},{"key":"739_CR53","doi-asserted-by":"publisher","first-page":"e0168921","DOI":"10.1128\/JCM.01689-21","volume":"60","author":"B Autier","year":"2022","unstructured":"Autier B, Prattes J, White PL, Valerio M, Machado M, Price J, et al. Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a multicenter study. J Clin Microbiol. 2022;60:e0168921. https:\/\/doi.org\/10.1128\/JCM.01689-21.","journal-title":"J Clin Microbiol"},{"key":"739_CR54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/myc.13518","volume":"65","author":"M Ghazanfari","year":"2022","unstructured":"Ghazanfari M, Yazdani Charati J, Davoodi L, Arastehfar A, Moazeni M, Abastabar M, et al. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis. Mycoses. 2022;65:960\u20138. https:\/\/doi.org\/10.1111\/myc.13518.","journal-title":"Mycoses"},{"key":"739_CR55","doi-asserted-by":"publisher","first-page":"e00598","DOI":"10.1128\/JCM.00598-21","volume":"59","author":"K Jani","year":"2021","unstructured":"Jani K, McMillen T, Morjaria S, Babady NE. Performance of the s\u014dna Aspergillus galactomannan lateral flow assay in a cancer patient population. J Clin Microbiol. 2021;59:e00598-e621. https:\/\/doi.org\/10.1128\/JCM.00598-21.","journal-title":"J Clin Microbiol"},{"key":"739_CR56","doi-asserted-by":"publisher","first-page":"e1737","DOI":"10.1093\/cid\/ciaa1281","volume":"73","author":"JD Jenks","year":"2021","unstructured":"Jenks JD, Prattes J, Frank J, Spiess B, Mehta SR, Boch T, et al. Performance of the bronchoalveolar lavage fluid Aspergillus galactomannan lateral flow assay with cube reader for diagnosis of invasive pulmonary aspergillosis: a multicenter cohort study. Clin Infect Dis. 2021;73:e1737\u201344. https:\/\/doi.org\/10.1093\/cid\/ciaa1281.","journal-title":"Clin Infect Dis"},{"key":"739_CR57","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12281-020-00409-z","volume":"14","author":"JD Jenks","year":"2020","unstructured":"Jenks JD, Miceli MH, Prattes J, Mercier T, Hoenigl M. The Aspergillus lateral flow assay for the diagnosis of invasive aspergillosis: an update. Curr Fungal Infect Rep. 2020;14:378\u201383. https:\/\/doi.org\/10.1007\/s12281-020-00409-z.","journal-title":"Curr Fungal Infect Rep"},{"key":"739_CR58","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.3390\/jof6040297","volume":"6","author":"KA Linder","year":"2020","unstructured":"Linder KA, Kauffman CA, Miceli MH. Performance of Aspergillus galactomannan lateral flow assay on bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis. J Fungi (Basel). 2020;6:E297. https:\/\/doi.org\/10.3390\/jof6040297.","journal-title":"J Fungi (Basel)"},{"key":"739_CR59","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","volume":"24","author":"T Mercier","year":"2020","unstructured":"Mercier T, Dunbar A, Veldhuizen V, Holtappels M, Schauwvlieghe A, Maertens J, et al. Point of care aspergillus testing in intensive care patients. Crit Care. 2020;24:642. https:\/\/doi.org\/10.1186\/s13054-020-03367-7.","journal-title":"Crit Care"},{"key":"739_CR60","doi-asserted-by":"publisher","first-page":"e1783","DOI":"10.1093\/cid\/ciaa1667","volume":"73","author":"M Mikulska","year":"2021","unstructured":"Mikulska M, Furfaro E, Bassetti M. The importance of quantitative results of a lateral flow aspergillus assay: the significant impact on specificity. Clin Infect Dis. 2021;73:e1783\u20134. https:\/\/doi.org\/10.1093\/cid\/ciaa1667.","journal-title":"Clin Infect Dis"},{"key":"739_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/myc.13216","volume":"64","author":"CM Roman-Montes","year":"2021","unstructured":"Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomel\u00ed P, Cervantes-Sanchez A, Rangel-Cordero A, Sifuentes-Osornio J, et al. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses. 2021;64:364\u201371. https:\/\/doi.org\/10.1111\/myc.13216.","journal-title":"Mycoses"},{"key":"739_CR62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/jof8070741","volume":"8","author":"R Almeida-Paes","year":"2022","unstructured":"Almeida-Paes R, Almeida MDA, de Macedo PM, Caceres DH, Zancop\u00e9-Oliveira RM. Performance of two commercial assays for the detection of serum aspergillus galactomannan in non-neutropenic patients. J Fungi (Basel). 2022;8:741. https:\/\/doi.org\/10.3390\/jof8070741.","journal-title":"J Fungi (Basel)"},{"key":"739_CR63","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/myc.13352","volume":"64","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Egger M, Boyer J, Schulz E, Prattes J, Jenks JD. Serum lateral flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: a two-centre mixed cohort study. Mycoses. 2021;64:1197\u2013202. https:\/\/doi.org\/10.1111\/myc.13352.","journal-title":"Mycoses"},{"key":"739_CR64","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/myc.13265","volume":"64","author":"I Serin","year":"2021","unstructured":"Serin I, Dogu MH. Serum aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: a single-centre study. Mycoses. 2021;64:678\u201383. https:\/\/doi.org\/10.1111\/myc.13265.","journal-title":"Mycoses"},{"key":"739_CR65","doi-asserted-by":"publisher","first-page":"e01006","DOI":"10.1128\/JCM.01006-20","volume":"58","author":"PL White","year":"2020","unstructured":"White PL, Price JS, Posso R, Vale L, Backx M. An evaluation of the performance of the IMMY aspergillus galactomannan enzyme-linked immunosorbent assay when testing serum to aid in the diagnosis of invasive aspergillosis. J Clin Microbiol. 2020;58:e01006-e1020. https:\/\/doi.org\/10.1128\/JCM.01006-20.","journal-title":"J Clin Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-023-00739-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:13:14Z","timestamp":1696939994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-023-00739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s11046-023-00739-9","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"26 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KL received consultancy fees from MRM Health and MSD, speaker fees from Pfizer and Gilead, and a service fee from Thermo fisher Scientific and TECOmedical. JM reports grants and personal fees from Bio-Rad, personal fees and non-financial support from Astellas and Basilea, and grants, personal fees and non-financial support from Gilead Sciences, Merck Sharp and Dohme, and Pfizer, Inc. TM has received consultancy fees from Gilead Sciences, Pfizer and AstraZeneca, research grants from Gilead Sciences, and travel support from AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}